Kennon-Green & Company’s Pfizer PFE Stock Holding History

Kennon-Green & Company’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-7,313	Closed	-$205K	–	44
2024 Q2	$205K	Sell	7,313 -1,327	-15%	-$36.5K	0.19%	43
2024 Q1	$240K	Buy	8,640 +804	+10%	+$22.3K	0.22%	42
2023 Q4	$226K	Sell	7,836 -3,775	-33%	-$114K	0.23%	42
2023 Q3	$385K	Sell	11,611 -440	-4%	-$15.6K	0.38%	36
2023 Q2	$442K	Buy	12,051 +590	+5%	+$23K	0.41%	35
2023 Q1	$468K	Sell	11,461 -335	-3%	-$14.5K	0.44%	35
2022 Q4	$604K	Buy	+11,796	New	+$566K	0.6%	32

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Kennon-Green & Company's PFE Position: Q3 2024 in Review

Kennon-Green & Company sold out of Pfizer (PFE) in Q3 2024, closing a stake of 7,313 shares — an estimated $205K sold.

Kennon-Green & Company first reported a position in PFE in Q4 2022 and held it in 7 quarters. The position peaked at $604K in Q4 2022. 2,910 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

Kennon-Green & Company reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
Kennon-Green & Company sold 7,313 Pfizer shares in Q3 2024, an estimated $205K.
Kennon-Green & Company first reported a position in Pfizer in Q4 2022 and held it in 7 quarters.
Kennon-Green & Company's Pfizer position peaked at $604K in Q4 2022.
2,910 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Kennon-Green & Company's 13F filing for Q3 2024, filed 31 Oct 2024.